| Date | Form | Description | Docs | XBRL | Pages |
| 03/24/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/17/14 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
74 |
| 03/13/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
8 | |
| 03/13/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 03/06/14 | UPLOAD | SEC-generated letter |
|
4 | |
| 03/06/14 | UPLOAD | SEC-generated letter |
|
3 | |
| 02/11/14 | S-3 | Registration statement for specified transactions by certain issuers |
|
102 | |
| 02/11/14 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
36 | |
| 02/07/14 | S-3 | Registration statement for specified transactions by certain issuers |
|
96 | |
| 02/05/14 | EFFECT | Notice of Effectiveness |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...